Genetically modified T-cell therapy targeting ROR1

ROR1-directed T-cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genetically modified T-cell therapy targeting ROR1, covering 2022-08-31 to 2022-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies [Phase 1]

See pricing